SCHEMBL18985152

SCHEMBL18985152

Cc1cc(OC(=O)c2ccc(O[Si](C(C)C)(C(C)C)C(C)C)cc2)ccc1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.46
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
HIF1A Q16665 2/20 0.44
MRGPRX4 Q96LA9 5/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
FFAR1 O14842 2/20 0.41
MAOB P27338 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPK1 P28482 1/20 0.41
HPGD P15428 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29783373 1.00 FFAR4 (0.46) FFAR4RXRARXRBRXRGHIF1A
SCHEMBL7713567 0.86 FFAR4 (0.56) FFAR4RXRARXRBRXRGHIF1A
SCHEMBL18985175 0.86 PPARG (0.42) FFAR4RXRARXRBRXRGHIF1A
SCHEMBL29783189 0.86 PPARG (0.42) FFAR4RXRARXRBRXRGHIF1A
SCHEMBL23824146 0.85 FFAR4 (0.48) FFAR4RXRARXRBRXRGMRGPRX4
SCHEMBL23036169 0.85 HIF1A (0.45) HIF1AMRGPRX4MAOBNPC1RAB9A
SCHEMBL23036220 0.78 ALDH1A1 (0.59) MAOBNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL29783272 0.77 NR1H4 (0.47) MAPTKMT2AHPGD
SCHEMBL18985158 0.77 NR1H4 (0.47) MAPTKMT2AHPGD
SCHEMBL18985160 0.76 FFAR4 (0.59) FFAR4RXRARXRBRXRGMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3784751-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2024-08-07 EP disclosed
EP-3784750-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2022-06-15 EP disclosed
US-11312907-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2022-04-26 US disclosed
US-11312907-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2022-04-26 US disclosed
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2022-04-07 US disclosed
EP-3864111-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2021-08-18 EP disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
US-20210071081-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2021-03-11 US disclosed
US-20210071081-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2021-03-11 US disclosed
EP-3784751-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2021-03-03 EP disclosed
EP-3784750-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2021-03-03 EP disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
EP-3390570-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-03-18 EP disclosed
EP-3390570-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2018-10-24 EP disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY CXCR1, PYM1, F11 FFAR4 3848/4885RXRA 2297/4885RXRB 2247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.